Latest News- Insomnia Therapeutics Market: Drug is expected to lead the Type segment during 2025-2029

The Insomnia Therapeutics Market is being driven by Increasing prevalence of insomnia

The Insomnia Therapeutics Market is expected to grow at a CAGR of 5.9% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 1198.6 million. The global insomnia therapeutics market is witnessing a significant shift towards non-pharmacological therapies, driven by growing awareness of the importance of addressing the root causes of insomnia and concerns regarding the potential side effects and risks associated with pharmacological treatments. One such effective non-pharmacological therapy is Cognitive-Behavioral Therapy for Insomnia (CBT-I), which aims to identify and modify the detrimental behaviors and thought patterns contributing to sleep disorders. Extensively researched and validated, CBT-I has proven to be highly effective in improving sleep quality and alleviating insomnia symptoms, often surpassing the benefits of pharmaceutical interventions. 

Get more information on Insomnia Therapeutics Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Type
  • Drug
  • Devices
• Distribution Channel
  • Prescription
  • OTC
• Drug Class
  • Non-benzodiazepines
  • Benzodiazepines
  • Antidepressants
  • Orexin receptor antagonists
  • Melatonin receptor agonists
• Geography
  • North America
    • Canada
    • Mexico
    • US
  • Asia
    • China
    • India
    • Japan
    • South Korea
  • Europe
    • Germany
    • UK
    • France
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Increasing prevalence of insomnia
• Technological advancements in diagnostics and treatment
• Rising healthcare expenditure and insurance coverage

However, the market also witnesses some limitations, which are as follows:

• Lack of awareness of insomnia as disease
• Concerns about safety and efficacy of insomnia therapeutics
• Regulatory and reimbursement issues in insomnia therapeutics

Benefits of Buying Global Insomnia Therapeutics Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Insomnia Therapeutics Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Insomnia Therapeutics Market encompasses various aspects of insomnia treatment, including sleep medication comparisons, adherence to insomnia treatment guidelines, advancements in sleep neurophysiology research, and sleep staging criteria. Key areas of focus include sleep-related breathing disorders, sleep-wake transition, and sleep architecture disruption. Sleep regulatory mechanisms, promoting substances, and diagnostic tools like sleep electroencephalography, electrooculography, and electromyography are also integral. Chronic insomnia treatment strategies, sleep continuity disruption evaluation, sleep quality metrics such as the sleep efficiency index and sleepiness severity rating, sleep disorder epidemiology, therapeutics, prevention, and sleep medicine technologies are all crucial components of this market.

Market Research Overview

The Insomnia Therapeutics Market is a significant segment of the global pharmaceuticals industry, focusing on the development and production of sleep disorder treatments. This market encompasses entities involved in research and development (R&D) as well as manufacturing of generic and non-generic insomnia medications, and sleep hygiene products. According to Technavio, the global pharmaceuticals market size is determined by the consolidated revenue of providers in the equipment, supplies, pharmaceuticals, biotechnology, and life sciences sectors. Factors propelling market expansion include the increasing elderly population, with Europe and the US projected to have over 25% of their populations aged 60 and above by 2030 and 2050, respectively. Effective insomnia treatments, such as cognitive behavioral therapy and sleep hygiene techniques, will be crucial in addressing the sleep disorders that disproportionately affect the elderly population. The market's growth is further fueled by the need for more effective and accessible insomnia treatments to improve overall patient quality of life.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/